Clinical Stage I Gastric Cancer AJCC v8

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Clinical Stage I Gastric Cancer AJCC v8 trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1/2

NCT05269381

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

This phase I/II trial tests the safety and tolerability of an experimental personalized vaccine when given by itself and with pembrolizumab in treating patients…

United States132 participantsStarted 2022-03-31

Treatment: Cyclophosphamide, Neoantigen Peptide Vaccine

All recent trials (16 shown)

Active — Not RecruitingPhase 2

NCT05836584

Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophagea…

This phase II trial compares atezolizumab in combination with chemotherapy (docetaxel, oxaliplatin, leucovorin calcium, fluorouracil, capecitabine) to atezolizu…

United States240 participantsStarted 2023-12-06

Treatment: Atezolizumab, Biospecimen Collection

Active — Not RecruitingPhase 1

NCT04220827

Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer

This phase I trial studies the side effects and best dose of paclitaxel for the treatment of gastric or gastroesophageal cancer. Drugs used in chemotherapy, suc…

United States27 participantsStarted 2019-12-06

Treatment: Paclitaxel

Clinical Stage I Gastric Cancer AJCC v8

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

All recent trials (16 shown)

Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophagea…

Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

All recent trials (16 shown)

Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophagea…

Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer

Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer

A Prospective Study of Physical Function in Adults Who Receive Systemic Therapy for Stage I-III Gastroesophageal Cancer,…

Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors

Individually Tailored, Supervised, Remote Exercise Intervention to Improve Physical Function for Stage I-III Gastroesoph…

Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric Cancer Unde…

Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma

Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for the Treatment of Patients With Gastric and G…

Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes

A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma

Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study

Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers

Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastati…

Clinical Trial to Evaluate the Efficacy and Safety of a Thoracic and Abdominal Endoscopic Surgical System